Investigation of the potential mechanisms associated with the effects of the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 on vascular endothelial injury

Background Coronary atherosclerotic heart disease is a major cardiovascular disease that poses a serious threat to human health. Quinazoline derivatives possess diverse biological activities and considerable structural modifiability, making them valuable candidates for drug development. Objective This study aimed to investigate the potential mechanism by which the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 protects against vascular endothelial injury. Methods Network pharmacology, single-cell transcriptomic analysis, and functional experiments were integrated to identify and prioritize a candidate functional target of KZL-064. An oscillatory shear stress-induced endothelial cell injury model was established to evaluate the protective effects of KZL-064. The functional involvement of the candidate target was further examined through HDAC1 overexpression and knockdown experiments. Results HDAC1 was identified as a prioritized candidate functional target potentially associated with the effects of KZL-064 and was significantly upregulated in atherosclerotic lesions. HDAC1 overexpression aggravated endothelial injury, whereas KZL-064 markedly alleviated oscillatory shear stress-induced damage. This protective effect was substantially diminished following HDAC1 knockdown. Further analysis indicated that KZL-064 was associated with the partial restoration of endothelial homeostasis and the modulation of inflammatory and cell cycle-related genes in an HDAC1-related context. Conclusion KZL-064 alleviates OSS-induced endothelial cell injury and is associated with modulation of inflammatory and cell cycle-related genes. HDAC1 was identified as a prioritized candidate functional target potentially involved in the action of KZL-064. These findings suggest potential relevance to atherosclerosis-associated endothelial dysfunction, while direct HDAC1 binding, enzymatic inhibition, target selectivity, and in vivo anti-atherosclerotic efficacy remain to be established.

Authors

Institutions

Publication Details

Journal
Technology and Health Care
Published
2026-11-19
DOI
https://doi.org/10.1177/09287329261498663
Primary Topic
Quinazolinone synthesis and applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Investigation of the potential mechanisms associated with the effects of the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 on vascular endothelial injury

Wangliang Zhu, Xudong Cui, Qi Zhang, Guojian Sun et al.
Technology and Health Care
Quinazolinone synthesis and applications
article

Investigation of the potential mechanisms associated with the effects of the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 on vascular endothelial injury

Wangliang Zhu, Xudong Cui, Qi Zhang, Guojian Sun, Zhifang Guan, Jianfei Li, Lidong Xu
article en

Abstract

Background Coronary atherosclerotic heart disease is a major cardiovascular disease that poses a serious threat to human health. Quinazoline derivatives possess diverse biological activities and considerable structural modifiability, making them valuable candidates for drug development. Objective This study aimed to investigate the potential mechanism by which the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 protects against vascular endothelial injury. Methods Network pharmacology, single-cell transcriptomic analysis, and functional experiments were integrated to identify and prioritize a candidate functional target of KZL-064. An oscillatory shear stress-induced endothelial cell injury model was established to evaluate the protective effects of KZL-064. The functional involvement of the candidate target was further examined through HDAC1 overexpression and knockdown experiments. Results HDAC1 was identified as a prioritized candidate functional target potentially associated with the effects of KZL-064 and was significantly upregulated in atherosclerotic lesions. HDAC1 overexpression aggravated endothelial injury, whereas KZL-064 markedly alleviated oscillatory shear stress-induced damage. This protective effect was substantially diminished following HDAC1 knockdown. Further analysis indicated that KZL-064 was associated with the partial restoration of endothelial homeostasis and the modulation of inflammatory and cell cycle-related genes in an HDAC1-related context. Conclusion KZL-064 alleviates OSS-induced endothelial cell injury and is associated with modulation of inflammatory and cell cycle-related genes. HDAC1 was identified as a prioritized candidate functional target potentially involved in the action of KZL-064. These findings suggest potential relevance to atherosclerosis-associated endothelial dysfunction, while direct HDAC1 binding, enzymatic inhibition, target selectivity, and in vivo anti-atherosclerotic efficacy remain to be established.

Technology and Health Care
Inner Mongolia People's Hospital (CN), Inner Mongolia Medical University (CN)
Quinazolinone synthesis and applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon